Infirst’s treatment for chronic wounds now available on NHS
Infirst Healthcare’s haemoglobin spray granulox, for the treatment of chronic wounds, has been added to the NHS Drug Tariff Part IX, establishing a new Haemoglobin category. The first treatment of its kind, granulox will be available on prescription across the UK from 1st October 2016.
Click on this link for more information.
